Axonal charcot-marie-tooth disease

Current Opinion in Neurology

Volumn 24, Issue 5, 2011, Pages 475-483

  Shy, Michael E ^a   Patzkó, Ágnes ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AR CMT2; axonal; CMT2; neuropathy

Indexed keywords

BERARDINELLI SEIP CONGENITAL LIPODYSTROPHY PROTEIN; DYNACTIN 1; DYNAMIN II; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN 22; HEAT SHOCK PROTEIN 27; IMMUNOGLOBULIN MU CHAIN; MITOFUSIN 1; MITOFUSIN 2; NERVE PROTEIN; RAB7 PROTEIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4;

CELLULAR DISTRIBUTION; CHROMOSOME 10Q; CHROMOSOME 12Q; CHROMOSOME 3Q; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOLECULAR MECHANICS; NERVE FIBER; NONHUMAN; PHENOTYPE; REVIEW;

AXONS; CHARCOT-MARIE-TOOTH DISEASE; HUMANS; NERVE TISSUE PROTEINS; NEURAL CONDUCTION;

EID: 80052436835     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32834aa331     Document Type: Review

References (86)

1. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980; 103:259-280. (Pubitemid 10046623)
2. Harding AE, Thomas PK. Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet 1980; 17:329-336. (Pubitemid 10018613)
3. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 1968; 18:619-625.
4. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968; 18:603-618.
5. Reilly MM, Shy ME. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry 2009; 80:1304-1314.
6. Warner LE, Mancias P, Butler IJ, et al. Mutations in the early growth response (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998; 18:382-384. (Pubitemid 28158170)
7. Topilko P, Schneider-Maunoury S, Levi G, et al. Krox-20 controls myelination in the peripheral nervous system. Nature 1994; 371:796-799. (Pubitemid 24333867)
8. Baxter RV, Ben Othmane K, Rochelle JM, et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 2002; 30:21-22.
9. Cuesta A, Pedrola L, Sevilla T, et al. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 2002; 30:22-25.
10. Niemann A, Ruegg M, La Padula V, et al. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 2005; 170:1067-1078. (Pubitemid 41362639)
11. Pedrola L, Espert A, Valdes-Sanchez T, et al. Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease. J Cell Mol Med 2008; 12:679-689. (Pubitemid 351555145)
12. Pedrola L, Espert A, Wu X, et al. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum Mol Genet 2005; 14:1087-1094. (Pubitemid 40575884)
13. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36:449-451. (Pubitemid 38620027)
14. Street VA, Bennett CL, Goldy JD, et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003; 60:22-26. (Pubitemid 36070638)
15. Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72:722-727. (Pubitemid 36255971)
16. Antonellis A, Ellsworth RE, Sambuughin N, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003; 72:1293-1299. (Pubitemid 36530017)
17. Zuchner S, Noureddine M, Kennerson M, et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 2005; 37:289-294. (Pubitemid 41716256)
18. Jordanova A, Irobi J, Thomas FP, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006; 38:197-202. (Pubitemid 43177233)
19. Bolino A, Muglia M, Conforti FL, et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 2000; 25:17-19. (Pubitemid 30257029)
20. Azzedine H, Bolino A, Taieb T, et al. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet 2003; 72:1141-1153. (Pubitemid 36530002)
21. Chen YZ, Bennett CL, Huynh HM, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004; 74:1128-1135. (Pubitemid 38669312)
22. Irobi J, Dierick I, Jordanova A, et al. Unraveling the genetics of distal hereditary motor neuronopathies. Neuromolecular Med 2006; 8:131-146.
23. Zuchner S, Vance JM. Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8:63-74.
24. Saporta ASD, Sottile SL, Miller LJ, et al. Charcot Marie Tooth (CMT) subtypes and genetic testing strategies. Ann Neurol 2011; 69:22-33.
25. Chen H, Chan DC. Emerging functions of mammalian mitochondrial fusion and fission. Hum Mol Genet 2005; 14 (Spec 2):R283-R289. (Pubitemid 41631897)
26. Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 2005; 280:26185-26192. (Pubitemid 41022214)
27. Pizzo P, Pozzan T. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics. Trends Cell Biol 2007; 17:511-517. (Pubitemid 47562768)
28. Lawson VH, Graham BV, Flanigan KM. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 2005; 65:197-204. (Pubitemid 41022361)
29. Zuchner S, De Jonghe P, Jordanova A, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 2006; 59:276-281. (Pubitemid 43202480)
30. Feely SM, Laura M, Siskind CE, et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 2011; 17:1690-1696.
31. Bejaoui K, Wu C, Scheffler MD, et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet 2001; 27:261-262. (Pubitemid 32201845)
32. Dawkins JL, Hulme DJ, Brahmbhatt SB, et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 2001; 27:309-312. (Pubitemid 32201853)
33. Klein CJ, Shi Y, Fecto F, et al. TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology 2011; 76:887-894.
34. Yoshioka R, Dyck PJ, Chance PF. Genetic heterogeneity in Charcot-Marie-Tooth neuropathy type 2. Neurology 1996; 46:569-571. (Pubitemid 26081356)
35. Landoure G, Zdebik AA, Martinez TL, et al. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 2010; 42:170-174.
36. Deng HX, Klein CJ, Yan J, et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010; 42:165-169.
37. Latour P, Thauvin-Robinet C, Baudelet-Mery C, et al. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 2010; 86:77-82.
38. McLaughlin HM, Sakaguchi R, Liu C, et al. Compound heterozygosity for lossof-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet 2010; 87:560-566.
39. Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 2008; 9:87-107.
40. Rohkamm B, Reilly MM, Lochmuller H, et al. Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome. J Neurol Sci 2007; 263:100-106. (Pubitemid 350029846)
41. Windpassinger C, Auer-Grumbach M, Irobi J, et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 2004; 36:271-276. (Pubitemid 38282752)
42. Irobi J, Van den Bergh P, Merlini L, et al. The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain 2004; 127:2124-2130. (Pubitemid 39150269)
43. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000; 67:37-46. (Pubitemid 30481542)
44. Ching GY, Liem RK. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of pre-existing cytoplasmic intermediate filaments. J Cell Biol 1993; 122:1323-1335. (Pubitemid 23277301)
45. Lee MK, Xu Z, Wong PC, Cleveland DW. Neurofilaments are obligate heteropolymers in vivo. J Cell Biol 1993; 122:1337-1350. (Pubitemid 23277302)
46. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 1994; 63:345-382.
47. Fabrizi GM, Cavallaro T, Angiari C, et al. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology 2004; 62:1429-1431. (Pubitemid 38526066)
48. Fabrizi GM, Cavallaro T, Angiari C, et al. Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton. Brain 2007; 130:394-403. (Pubitemid 46181093)
49. Sasaki T, Gotow T, Shiozaki M, et al. Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants. Hum Mol Genet 2006; 15:943-952. (Pubitemid 43338235)
50. Jordanova A, De Jonghe P, Boerkoel CF, et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 2003; 126:590-597. (Pubitemid 36240860)
51. Lemke G. Unwrapping the genes of myelin. Neuron 1988; 1:535-543.
52. Lemke G, Axel R. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 1985; 40:501-508. (Pubitemid 15076567)
53. Shapiro L, Doyle JP, Hensley P, et al. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996; 17:435-449. (Pubitemid 26322215)
54. Hayasaka K, Himoro M, Sato W, et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993; 5:31-34. (Pubitemid 23261514)
55. Shy ME, Jani A, Krajewski KM, et al. Phenotypic clustering in MPZ mutations. Brain 2004; 127:371-384. (Pubitemid 38160322)
56. De Jonghe P, Timmerman V, Ceuterick C, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 1999; 122 (Pt 2):281-290. (Pubitemid 29067210)
57. Li J, Bai Y, Ianakova E, et al. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration. J Comp Neurol 2006; 498:252-265. (Pubitemid 44182464)
58. Krajewski KM, Lewis RA, Fuerst DR, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000; 123:1516-1527. (Pubitemid 30420950)
59. Dyck PJ. Inherited neuronal degeneration and atrophy affecting peripheral motor, sensory and autonomic neurons. In: Dyck PJ TP, Lambert EH, editors. Peripheral neuropathy. Philadelphia: Saunders; 1975. p. 825.
60. Berg BO, Rosenberg SH, Asbury AK. Giant axonal neuropathy. Pediatrics 1972; 49:894-899.
61. Asbury AK, Gale MK, Cox SC, et al. Giant axonal neuropathy: a unique case with segmental neurofilamentous masses. Acta Neuropathol 1972; 20:237-247.
62. Ouvrier RA, Prineas J, Walsh JC, et al. Giant axonal neuropathy: a third case. Proc Aust Assoc Neurol 1974; 11:137-144.
63. Bomont P, Cavalier L, Blondeau F, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 2000; 26:370-374.
64. Kuhlenbaumer G, Young P, Oberwittler C, et al. Giant axonal neuropathy (GAN): case report and two novel mutations in the gigaxonin gene. Neurology 2002; 58:1273-1276. (Pubitemid 34411874)
65. Stogios PJ, Prive GG. The BACK domain in BTB-kelch proteins. Trends Biochem Sci 2004; 29:634-637. (Pubitemid 39491260)
66. Evgrafov OV, Mersiyanova I, Irobi J, et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004; 36:602-606. (Pubitemid 38715987)
67. Irobi J, Van Impe K, Seeman P, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004; 36:597-601. (Pubitemid 38715986)
68. d'Ydewalle C, Krishnan J, Timmerman V, Van Den Bosch L. The small heat shcok proteins: cellular functions and mutations causing neurodegeneration. In: O'Connor AWaV, editor. Folding for the synapse. Springer Science-Business Media; LLC2011, 2011. pp. 49-76.
69. Grohmann K, Schuelke M, Diers A, et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet 2001; 29:75-77. (Pubitemid 32801813)
70. Puls I, Oh SJ, Sumner CJ, et al. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann Neurol 2005; 57:687-694. (Pubitemid 40628857)
71. Claramunt R, Pedrola L, Sevilla T, et al. Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet 2005; 42:358-365. (Pubitemid 40523959)
72. Chung KW, Kim SM, Sunwoo IN, et al. A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease. J Hum Genet 2008; 53:360-364.
73. Bienfait HM, Baas F, Koelman JH, et al. Phenotype of Charcot-Marie-Tooth disease type 2. Neurology 2007; 68:1658-1667. (Pubitemid 46763252)
74. Cuesta A, Pedrola L, Sevilla T, et al. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 2001; 30:22-25.
75. Niemann A, Wagner KM, Ruegg M, Suter U. GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance. Neurobiol Dis 2009; 36:509-520.
76. Claeys KG, Zuchner S, Kennerson M, et al. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain 2009; 132:1741-1752.
77. Niemann A, Berger P, Suter U. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8:217-242.
78. Chow CY, Zhang Y, Dowling JJ, et al. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 2007; 448:68-72. (Pubitemid 47036999)
79. Zhang X, Chow CY, Sahenk Z, et al. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain 2008; 131:1990-2001.
80. Sbrissa D, Ikonomov OC, Fu Z, et al. Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. J Biol Chem 2007; 282:23878-23891. (Pubitemid 47328041)
81. Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006; 443:651-657. (Pubitemid 44564702)
82. Berger P, Bonneick S, Willi S, et al. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum Mol Genet 2002; 11:1569-1579. (Pubitemid 34679257)
83. Bolino A, Bolis A, Previtali SC, et al. Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J Cell Biol 2004; 167:711-721. (Pubitemid 39565151)
84. Katona I, Zhang X, Bai Y, et al. Distinct pathogenic processes between Fig4-deficient motor and sensory neurons. Eur J Neurosci 2011; 33:1401-1410.
85. Detmer SA, Chan DC. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J Cell Biol 2007; 176:405-414.
86. Liedtke W. TRPV4 plays an evolutionary conserved role in the transduction of osmotic and mechanical stimuli in live animals. J Physiol 2005; 567:53-58. (Pubitemid 41167304)